… overall survival of breast cancer patients with distant recurrence or de novo metastatic disease
… We found no evidence for an improvement in survival between 1980 and 1990, consistent …

… In the last 25 years new treatment options in breast cancer have evolved. We wanted to
determine whether the survival of; patients with metastatic breast cancer have improved during …

… modest, but meaningful survival advantages in metastatic disease. A common … survival
improvements. The role of the taxanes, antimetabolites, and biologics in extending survival …

… Patients with metastatic breast cancer have traditionally … that the survival of patients with
metastatic breast cancer has … group of patients with metastatic breast cancer. We identify that …

… explored survival outcomes for > 47,000 breast cancer patients with de novo metastatic …
While our analysis demonstrated the expected improvements in survival, it is noteworthy that the …

… Metastatic Breast Cancer (MBC) include a large variety of new palliative approaches [1]. A
decrease in overall breast cancer … approaches both in the adjuvant and metastatic setting [4]. …

… This article reviews the types of breast cancer and cancer … subtypes of breast cancer, symptoms
of metastatic breast cancer, … The 5-year survival rate is 26% for metastatic breast cancer. …

… In various series of hepatic resection for breast cancer metastases, the reported median
survival ranged from 14.5 to 63 months and the 5-year survival from 14% to 61%, in general, …

… survival in patients with metastatic breast cancer (12-16). Moreover, our data showed the
favorable prognostic role of PR positivity, which is in agreement with data in the literature (17), …

… of survival of 86 patients with metastatic breast cancer was … Survival from time of randomisation
and onset of intervention … Survival plots indicated that divergence in survival began at …